Your browser doesn't support javascript.
loading
Patient Characteristics Associated with Hospital Admission or Antiarrhythmic Medication Changes After Emergency Department Evaluation of Supraventricular Tachycardia.
Schmucker, Kyle A; Morris, Caroline S; Tisherman, Robert T; Manole, Mioara; Arora, Guarav; Dunnick, Jennifer.
Afiliación
  • Schmucker KA; Department of Pediatrics, Division of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. Kyle.schmucker@utsouthwestern.edu.
  • Morris CS; Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, USA.
  • Tisherman RT; UPMC Department of Orthopedics, Pittsburgh, USA.
  • Manole M; Department of Pediatrics, Division of Pediatric Emergency Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
  • Arora G; Department of Pediatrics, Division of Cardiology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
  • Dunnick J; Department of Pediatrics, Division of Pediatric Emergency Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
Pediatr Cardiol ; 44(8): 1710-1715, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37561172
BACKGROUND: Supraventricular tachycardia (SVT) is a relatively frequent diagnosis in the pediatric emergency department (ED). However, there are no consensus guidelines for ED disposition, and there are limited data on ED outcomes. Better understanding of those who are admitted or have antiarrhythmic medication changes may avoid potentially unnecessary transfers or admissions. Our objective was to identify patient factors associated with discharge from the emergency department without medication initiation or modification after management of SVT in the pediatric ED. DESIGN/METHODS: A retrospective review of children aged 0-18 years seen in the emergency department for SVT was conducted using electronic medical record data over a ten-year period at a single academic tertiary children's hospital. Patients with congenital cardiac disease or prior cardiac surgeries were excluded. Multivariable logistic regression analysis was used to determine association between patient factors of interest and the primary outcome of admission and secondary outcome of change to antiarrhythmic medications. RESULTS: We analyzed 197 patients encounters. The mean age was 7 years. Of these 104 (52.8%) were admitted to the hospital or discharged with antiarrhythmic medication changes. This primary outcome was associated with younger age (aOR 0.77, 95% CI 0.67-0.86), history of pre-excitation (aOR 5.82, 95% CI 2.01-18.8), intercurrent illness (aOR 3.75, 95% CI 1.27-12.1), number of adenosine doses prior to arrival (aOR 5.45, 95% CI 1.55-22.3), and in-person cardiology consultation (aOR 6.42, 95% CI 2.43-19.4). CONCLUSIONS: Nearly half of children treated in a pediatric ED for SVT are discharged without changes in medications. We identified patient factors associated with hospital admission or antiarrhythmic medication changes. These factors represent high value care and can be assessed when considering transfer from a referring facility. Risk stratification using these patient characteristics may reduce potentially avoidable transfers and admissions.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Taquicardia Supraventricular / Antiarrítmicos Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Pediatr Cardiol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Taquicardia Supraventricular / Antiarrítmicos Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Pediatr Cardiol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos